Biosensors Reports Record Product Revenues & Strong Sales of BioMatrix® Drug-Eluting Stents in First Fiscal Quarter

12.08.08 - 21:07 ... source : Biosensors International

... Times New RomanTimes New Roman NEWS RELEASE BIOSENSORS REPORTS RECORD PRODUCT REVENUES AND STRONG SALES OF BIOMATRIX® DRUG-ELUTING STENTS IN FIRST FISCAL QUARTER Singapore 12 August 2008 - Biosensors International Group, Ltd. ("Bio sensors" or the "Company", Bloomberg: BIG SP ) today announced record product revenues for its first quarter of fiscal year 2009 ended 30 June 2008 ("1Q FY09" ). For 1Q FY09 Biosensors reported product revenues of US$17.1 million, an 84% increase over the US$9.3 million reported in the first quarter of fiscal year 2008 ("1Q FY08" ). Product sales growth fo r the quarter was primarily attributable to increased drug-eluting stent sales, as such sales increased to US$7.2 million in th e current quarter compared to US$2.4 million in 1Q FY08, an increase of 204%. The increase in drug-elu ting stent sales is directly related to the commercial launch of the Company's BioMatrix drug-eluting stent system during th e quarter. Sales of other inte rventional cardiol ...» Next (PDF)